Oral Answers to Questions

Laurence Robertson Excerpts

Tuesday 7th May 2019 Commons Chamber

[Jackie Doyle-Price]

My hon. Friend is knocking on an open door, because this issue is very close to my heart. The public outcomes framework does include a measure of reported domestic abuse incidents and crimes that is intended to give an indication of the scale of the issue in each area, and we expect CCGs to commission services as a response to exactly those issues. I have written to CCGs to remind them to commission appropriate sexual violence services, as well as those already commissioned by NHS England so that we have proper support for people who have been victims of these terrible offences.

[Mr Laurence Robertson (Tewkesbury) (Con)]

T1. If he will make a statement on his departmental responsibilities.

[The Secretary of State for Health and Social Care (Matt Hancock)]

It is the goal of the Department to support everyone to live longer, healthier lives. I will be working right across the health and social care sector to deliver the goal of five years of extra healthy life for people in the UK. In doing that, I am delighted that we will now have on the ministerial team the enthusiasm and assistance of the Under-Secretary, my hon. Friend the Member for South Ribble (Seema Kennedy).

[Mr Robertson]

In achieving those goals, the Secretary of State will be concerned that while many patients can obtain GP appointments for emergency cases on the same day, quite a lot of people have to wait three or four weeks for non-emergency appointments. Can the Government do anything to improve that situation?

[Matt Hancock]

Yes, I entirely understand my hon. Friend’s concerns. We are acting to make sure that there is better access. We have a review of access to primary care. But, more than that, the biggest increase of the £39.9 billion of extra taxpayers’ money that we are putting into the NHS is in GP access, primary care and community care to make sure that we get ahead of the curve and help people to stay healthy rather than just treat them in hospital.

Oral Answers to Questions

Laurence Robertson Excerpts

Tuesday 26th March 2019 Commons Chamber

[Caroline Dinenage]

Most people are diagnosed and treated successfully by GPs and recover uneventfully, but in a few cases people who are diagnosed late or are not treated adequately may develop significant complications. That is why the National Institute for Health Research welcomes applications for research funds.

[Mr Laurence Robertson (Tewkesbury) (Con)]

22. Earlier this month I visited a young lady in my constituency who was living a perfectly good life but was then struck down by Lyme disease. She has not left the House in over 12 months and is in terrible pain all the time. The NHS in this country did not find a diagnosis from her blood sample; it had to be sent to Germany to get the diagnosis. An awful lot more needs to be done to help these people.

[Caroline Dinenage]

My hon. Friend is absolutely right to raise this: we do need to do more in this space, and that is why we are investing over £1 billion a year in health research through the National Institute of Health Research.

Diabetes

Laurence Robertson Excerpts

Wednesday 9th January 2019 Westminster Hall

[Mr Howarth]

Yes. I will not labour the point, but the hon. Gentleman is right. I would add that quite often teachers are left with such responsibilities, although they have enough challenges in their working life, but there is a need for someone in the school to have the expertise and to be trained to deal with young people with type 1 diabetes.

I know that I assured you, Mr Robertson, that I would try to be briefer than I have been, but I am coming to the end of my remarks, and the matter is important. I join the right hon. Member for South Holland and The Deepings in saying that it would be useful to have a meeting with the Minister to discuss the matter in more depth and get his thoughts on how to move forward. There is much that we can do to make people’s lives better. I hope that the debate will inform that process, and that we will be able to move forward on the basis of consensus across the House. The Minister faces challenges, and Members of this House will want to share the burden of them.

[Mr Laurence Robertson (in the Chair)]

I am looking to call the Scottish National party spokesman at 10.28, and we have two more hon. Members wanting to speak, so please bear that in mind.

Oral Answers to Questions

Laurence Robertson Excerpts

Tuesday 27th November 2018 Commons Chamber

[Mr Laurence Robertson (Tewkesbury) (Con)]

12. What recent estimate he has made of the number of people entering nursing higher education; and if he will make a statement.

[The Minister for Health (Stephen Hammond)]

The latest UCAS data from October 2018 show that demand for nursing courses remains strong, with applications exceeding the number of places available this year. The number of acceptances to nursing and midwifery courses in 2018 is consistent with earlier years at approximately 22,000. The final data will be published in December 2018.

[Mr Robertson]

Does the Minister accept that student nurses face pressures from the long hours they have to study and the long hours they spend on placements, which makes it very difficult for them also to carry out paid work? Is there any more the Government can do to support student nurses financially as they go through college?

[Stephen Hammond]

As my right hon. Friend the Secretary of State said earlier, we recognise the vital role that nurses play, and we are determined to support them. We are determined to have more nurses in training and more nurses treating patients. At the moment, a student on the loan system typically achieves 25% more in their pocket than they would have had on the bursary, but the Government recognise that there are still pressures, which is why we have the learning support fund, the exceptional hardship fund and support for mature students.

Phenylketonuria: Treatment and Support

Laurence Robertson Excerpts

Tuesday 26th June 2018 Westminster Hall

[Mr Laurence Robertson (in the Chair)]

Given the number of Members who will seek to catch my eye, I am imposing a four-minute time limit on Back-Bench speeches.

[Liz Twist (Blaydon) (Lab)]

I beg to move,

That this House has considered access to treatment, support and innovative new medicines for phenylketonuria patients.

It is a pleasure to serve under your chairmanship in this important debate, Mr Robertson. It is just over 12 months since I was elected Member of Parliament for Blaydon, and only a few days less than that since I first heard of phenylketonuria—commonly known as PKU, which is easier to pronounce. One of my constituents, Barbara McGovern, had called at my office and spoken to a member of my staff about whether I would attend an event in Westminster on 28 June. Barbara’s son Archie has PKU, and she described his condition and some of the restrictions that he has to cope with every day. Her explanation of what PKU means, and her determination to get the best for her son, impressed my staff, who made sure that I attended the reception to learn more about the condition. Barbara and her husband David, and Archie, have travelled from the north-east to listen to the debate, and I welcome them.

Since that first encounter, I have been lucky enough to be introduced to the officers of the National Society for Phenylketonuria, and have had the chance to work with them and its other members to raise the profile of PKU, get people to understand it and its effects, and press for access to treatment and support. I will give a few of the many names that I could mention. Kate Learoyd and Caroline Graham both have children with PKU, and they have dedicated much of their time to talking to Members about the condition and the need for action for people who live with PKU. Professor Anita MacDonald OBE, of Birmingham Children’s Hospital, also does much to raise awareness of the condition and goes above and beyond in advising families affected by PKU on diet.

--- Later in debate ---

[Chris Williamson (Derby North) (Lab)]

It is a pleasure to serve under your chairmanship, Mr Robertson. I congratulate my hon. Friend the Member for Blaydon (Liz Twist) on securing this important debate. We have heard some heartrending accounts from hon. Members about the impact of PKU on their constituents.

My constituent, Denise Clayton, whose family I have known for 30 years, has lived with PKU for nearly 70 years, so she was born long before any real screening programme was in place. Consequently, she did not receive the required treatment, and the treatment she did receive was too little, too late to avoid neurotoxicity. Her family have done everything they could to support Denise. A few weeks ago, I spoke to her father, Norman, who recounted some of the traumas and difficulties that they experienced down the years. His view was that nothing could be done for Denise, but it seems that a treatment is now available.

I join hon. Members in their pleas with the Minister to use his good offices to ensure that the new life-changing drug Kuvan is made available so that the sufferers of PKU in the UK—like sufferers in other countries—can obtain the benefits of it and lead something approaching a normal life. Let us remember that we live in a wealthy nation; we are the sixth-biggest economy in the world.

PKU is a very rare condition that affects only a very few people in total across the country. The cost of the drug would be minimal in comparison to the life-changing impact it could bring about for young people—our fellow citizens. I plead with the Minister to listen to the impassioned pleas we have heard from Members today. He should use his good offices to ensure that the drug is made available so that we can change the lives of so many young people in our country who are suffering from this terrible condition.

[Mr Laurence Robertson (in the Chair)]

We now come to the wind-ups. I would like to leave two minutes for the mover of the motion to wind up at the end.

--- Later in debate ---

[Liz Twist]

What can I say in less than one and a half minutes? I thank all hon. Members who have taken part today. I thank the hon. Members for East Renfrewshire (Paul Masterton), my hon. Friend the Member for Portsmouth South (Stephen Morgan), the hon. Member for Waveney (Peter Aldous), my hon. Friend the Member for Dudley North (Ian Austin), the hon. Members for Chelmsford (Vicky Ford), for Dwyfor Meirionnydd (Liz Saville Roberts) and for Strangford (Jim Shannon), my hon. Friends the Members for Warrington South (Faisal Rashid), for Hornsey and Wood Green (Catherine West) and for Derby North (Chris Williamson), the hon. Member for Linlithgow and East Falkirk (Martyn Day), my hon. Friend the Member for Washington and Sunderland West (Mrs Hodgson) and the Minister for his reply.

I am rather disappointed that we did not have a bit more promising news on the future of Kuvan, but we will be back; we will ensure that the Minister hears from us again, and we will continue our campaign. Finally, I thank all the families who are here today to show how strongly people feel about the issue. I thank everyone for attending. The issue will not go away. We will be back and will keep pushing this agenda.

Question put and agreed to.

Resolved,

That this House has considered access to treatment, support and innovative new medicines for phenylketonuria patients.

[Mr Laurence Robertson (in the Chair)]

Would hon. Members leaving please do so quietly? Thank you. We have another debate.